Skip to main content
. 2019 Jun 25;2019:3630260. doi: 10.1155/2019/3630260

Figure 7.

Figure 7

Schematic diagram of the main related metabolic pathways related to immunoregulation of PG. PC: PC (18:3(9Z,12Z,15Z)/15:0), PE:PE (18:0/16:1(9Z)), and PS:PS (18:0/20:4(8Z,11Z,14Z,17Z)). The red and light blue words indicate metabolites significantly increased and reduced, respectively, in the PG-treated group compared with the control group. The yellow boxes indicate metabolites that are affected by PG using network pharmacology analysis. The solid lines indicate that one metabolite produces another metabolite in less than two steps in KEGG metabolism pathway maps.